WELCINA-D contains Cinnarizine 20 mg + Domperidone 15 mg, providing complementary vestibular and antiemetic activity for vertigo-associated nausea and related symptoms. A useful PCD Pharma Vertigo/Anti-Emetic product.
Vertigo-associated nausea and certain motion-related symptoms.
Yes.
Avoid driving if drowsy. Use Domperidone-containing therapy cautiously in patients with cardiac risk factors or interacting medicines.
Drowsiness, dry mouth, nausea, constipation and dizziness may occur.
WELCINA-D: Cinnarizine helps reduce vestibular excitability and improves microcirculatory flow, while Domperidone supports gastrointestinal motility and provides antiemetic activity.
